← FDA DRUG APPROVALS

FDA NDA · NDA011679

PENTOTHAL

Sponsor: ABBOTT

APPLICATION
NDA011679
TYPE
NDA
ORIGINAL APPROVAL
1959-09-23
LATEST ACTION
2001-09-17
ROUTE
RECTAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

PENTOTHALDiscontinued
THIOPENTAL SODIUM 400MG/GM · SUSPENSION · RECTAL

Approval history

2001-09-17Labeling · Supplement 17AP
1995-03-30Labeling · Supplement 18 · standardAP
1984-02-15Labeling · Supplement 13AP
1977-01-24Labeling · Supplement 10AP
1976-09-10Labeling · Supplement 9AP
1975-10-20Labeling · Supplement 7AP
1971-08-30Labeling · Supplement 6AP
1959-09-23Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →